BRCA1 is Expressed in Uterine Serous Carcinoma (USC) and Controls Insulin-Like Growth Factor I Receptor (IGF-IR) Gene Expression in USC Cell Lines
Authors:
- 1 June 2012
- journal article
- research article
- Published by Elsevier in International Journal of Gynecological Cancer
- Vol. 22 (5) , 748-754
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- BRCA1/2 Germline Mutations in Jewish Patients With Uterine Serous CarcinomaInternational Journal of Gynecological Cancer, 2010
- Elevated insulin-like growth factor-I receptor (IGF-IR) levels in primary breast tumors associated with BRCA1 mutationsCancer Letters, 2007
- Expression and distribution of insulin-like growth factor-1 receptor in human carcinomasHuman Pathology, 2003
- BRCA1–Sp1 interactions in transcriptional regulation of the IGF‐IR geneFEBS Letters, 2003
- IGF-I receptor signalling in transformation and differentiationMolecular Pathology, 2001
- BRCA1 Suppresses Insulin-like Growth Factor-I Receptor Promoter Activity: Potential Interaction between BRCA1 and Sp1Molecular Genetics and Metabolism, 2000
- Differentiation and malignant transformation: Two roads diverged in a woodJournal of Cellular Biochemistry, 1999
- Increased Circulating Levels of Insulin-Like Growth Factor-I and Decreased Circulating Levels of Insulin-Like Growth Factor Binding Protein-1 in Postmenopausal Women with Endometrial Cancer.Endocrine Journal, 1997
- Molecular and Cellular Aspects of the Insulin-Like Growth Factor I ReceptorEndocrine Reviews, 1995
- Uterine papillary serous carcinomaAmerican Journal of Surgical Pathology, 1982